Podcast
Questions and Answers
What is the incidence of intrahepatic cholangiocarcinoma (IHCC) in the United States?
What is the incidence of intrahepatic cholangiocarcinoma (IHCC) in the United States?
- 2.00 per 100,000
- 1.25 per 100,000
- 0.85 per 100,000 (correct)
- 0.35 per 100,000
IHCC accounts for approximately 20% of primary hepatic malignancies.
IHCC accounts for approximately 20% of primary hepatic malignancies.
False (B)
In which decade of life do patients typically present with intrahepatic cholangiocarcinoma?
In which decade of life do patients typically present with intrahepatic cholangiocarcinoma?
seventh decade
Primary Sclerosing Cholangitis is the most common risk factor for __________ in the West.
Primary Sclerosing Cholangitis is the most common risk factor for __________ in the West.
Match the following terms with their descriptions:
Match the following terms with their descriptions:
Which factor is most commonly recognized as influencing the development of IHCC?
Which factor is most commonly recognized as influencing the development of IHCC?
The recognition of IHCC as a distinct primary liver cancer occurred early in medical history.
The recognition of IHCC as a distinct primary liver cancer occurred early in medical history.
What type of lesions did many IHCC cases get historically misdiagnosed as?
What type of lesions did many IHCC cases get historically misdiagnosed as?
What is the survival benefit for patients undergoing hepatectomy with portal lymphadenectomy?
What is the survival benefit for patients undergoing hepatectomy with portal lymphadenectomy?
Routine dissection of cardia and lesser curvature nodes for left-sided tumors is associated with improved survival rates.
Routine dissection of cardia and lesser curvature nodes for left-sided tumors is associated with improved survival rates.
What classification is used to describe the stage of a tumor in the study?
What classification is used to describe the stage of a tumor in the study?
In the classification system, T1 meets all requirements, while T2 meets ____ of the three requirements.
In the classification system, T1 meets all requirements, while T2 meets ____ of the three requirements.
Match the classification letters with their corresponding definitions:
Match the classification letters with their corresponding definitions:
Which surgical approach has been associated with higher mortality?
Which surgical approach has been associated with higher mortality?
What treatments are currently under investigation for liver cancer management?
What treatments are currently under investigation for liver cancer management?
More than half of patients undergoing surgery for liver cancer typically do not have routine lymphadenectomy performed.
More than half of patients undergoing surgery for liver cancer typically do not have routine lymphadenectomy performed.
Which of the following factors can act as external stimuli to induce chronic inflammation in the liver?
Which of the following factors can act as external stimuli to induce chronic inflammation in the liver?
Chronic inflammation can lead to the deregulation of signaling pathways such as EGFR and IL-6/STAT3.
Chronic inflammation can lead to the deregulation of signaling pathways such as EGFR and IL-6/STAT3.
What type of cell undergoes malignant transformation due to certain epigenetic and genetic alterations?
What type of cell undergoes malignant transformation due to certain epigenetic and genetic alterations?
The presence of ____________ can lead to DNA hypermethylation in cholangiocytes, contributing to neoplastic changes.
The presence of ____________ can lead to DNA hypermethylation in cholangiocytes, contributing to neoplastic changes.
Match the following genetic alterations with their types:
Match the following genetic alterations with their types:
Which of the following signaling pathways is NOT commonly associated with malignancy in cholangiocytes?
Which of the following signaling pathways is NOT commonly associated with malignancy in cholangiocytes?
Deregulated signaling can enhance the invasive and metastatic potential of malignant cholangiocytes.
Deregulated signaling can enhance the invasive and metastatic potential of malignant cholangiocytes.
Name one microRNA that is deregulated in the neoplastic transformation of cholangiocytes.
Name one microRNA that is deregulated in the neoplastic transformation of cholangiocytes.
What is the primary cell type involved in the development of cholangiocarcinoma?
What is the primary cell type involved in the development of cholangiocarcinoma?
The mass-forming type of IHCC is characterized by infiltrative behavior without forming a discrete nodular shape.
The mass-forming type of IHCC is characterized by infiltrative behavior without forming a discrete nodular shape.
What are the two main types of IHCC classified by Nakanuma and colleagues?
What are the two main types of IHCC classified by Nakanuma and colleagues?
Cholangiocytes play a role in the _____ of bile at the canalicular surface.
Cholangiocytes play a role in the _____ of bile at the canalicular surface.
Match the morphologic type of IHCC with its characteristic:
Match the morphologic type of IHCC with its characteristic:
Which of the following observations about cholangiocarcinogenesis is accurate?
Which of the following observations about cholangiocarcinogenesis is accurate?
All three morphologic types of IHCC show the same proliferative activity and biological behavior.
All three morphologic types of IHCC show the same proliferative activity and biological behavior.
What is the primary feature distinguishing the mass-forming type of hepatic cholangiocarcinoma from the infiltrative type?
What is the primary feature distinguishing the mass-forming type of hepatic cholangiocarcinoma from the infiltrative type?
What is the role of normal growth and renewal of cholangiocytes?
What is the role of normal growth and renewal of cholangiocytes?
Intrahepatic cholangiocarcinomas and hepatic cholangiocarcinomas do not share genetic aberrations.
Intrahepatic cholangiocarcinomas and hepatic cholangiocarcinomas do not share genetic aberrations.
Name one cytokine that cholangiocytes secrete.
Name one cytokine that cholangiocytes secrete.
Chronic inflammation often results in ________ to the biliary epithelium.
Chronic inflammation often results in ________ to the biliary epithelium.
What is recommended as the procedure of choice for the mass-forming subtype of cholangiocarcinoma?
What is recommended as the procedure of choice for the mass-forming subtype of cholangiocarcinoma?
Chronic inflammation decreases cholangiocyte turnover.
Chronic inflammation decreases cholangiocyte turnover.
What is the fourth subtype of cholangiocarcinoma identified by investigators?
What is the fourth subtype of cholangiocarcinoma identified by investigators?
Match the subtype of cholangiocarcinoma with its characteristic feature.
Match the subtype of cholangiocarcinoma with its characteristic feature.
Which factor is associated with an increased risk of cholangiocarcinoma?
Which factor is associated with an increased risk of cholangiocarcinoma?
Hepatolithiasis is not associated with the risk of developing cholangiocarcinoma.
Hepatolithiasis is not associated with the risk of developing cholangiocarcinoma.
What percentage of IHCC patients may have nonalcoholic steatohepatitis?
What percentage of IHCC patients may have nonalcoholic steatohepatitis?
The syndrome characterized by recurrent episodes of cholangitis and hepatolithiasis is known as _____.
The syndrome characterized by recurrent episodes of cholangitis and hepatolithiasis is known as _____.
What is a rare consequence of untreated biliary cystadenomas?
What is a rare consequence of untreated biliary cystadenomas?
Cholangiocarcinomas have the same incidence in HIV patients compared to non-HIV controls.
Cholangiocarcinomas have the same incidence in HIV patients compared to non-HIV controls.
What condition may reflect lifestyle rather than represent an etiologic factor for IHCC?
What condition may reflect lifestyle rather than represent an etiologic factor for IHCC?
Match the following conditions with their associated risks:
Match the following conditions with their associated risks:
Flashcards
Intrahepatic Cholangiocarcinoma (IHCC)
Intrahepatic Cholangiocarcinoma (IHCC)
A type of liver cancer originating from the bile duct cells within the liver.
Intrahepatic Bile Duct Cancers
Intrahepatic Bile Duct Cancers
A group of primary liver cancers that develop in the bile ducts within the liver.
Incidence of IHCC
Incidence of IHCC
A rare type of liver cancer, accounting for around 10% of primary liver cancers.
Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis (PSC)
Signup and view all the flashcards
Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis (PSC)
Signup and view all the flashcards
Chronic Inflammation of the Biliary Epithelium
Chronic Inflammation of the Biliary Epithelium
Signup and view all the flashcards
Advanced Diagnosis of IHCC
Advanced Diagnosis of IHCC
Signup and view all the flashcards
IHCC Occurrence
IHCC Occurrence
Signup and view all the flashcards
Recurrent Pyogenic Cholangiohepatitis
Recurrent Pyogenic Cholangiohepatitis
Signup and view all the flashcards
Hepatolithiasis
Hepatolithiasis
Signup and view all the flashcards
Chronic Bile Stasis
Chronic Bile Stasis
Signup and view all the flashcards
Biliary Cystadenoma
Biliary Cystadenoma
Signup and view all the flashcards
Biliary Cystadenocarcinoma
Biliary Cystadenocarcinoma
Signup and view all the flashcards
Nonalcoholic Steatohepatitis (NASH)
Nonalcoholic Steatohepatitis (NASH)
Signup and view all the flashcards
Ascending Cholangitis
Ascending Cholangitis
Signup and view all the flashcards
HCC and IHCC connection
HCC and IHCC connection
Signup and view all the flashcards
Chronic inflammation and cancer
Chronic inflammation and cancer
Signup and view all the flashcards
Chronic inflammation effects
Chronic inflammation effects
Signup and view all the flashcards
Cholangiocytes and cancer
Cholangiocytes and cancer
Signup and view all the flashcards
Cholangiocyte secretions
Cholangiocyte secretions
Signup and view all the flashcards
Yamamoto classification
Yamamoto classification
Signup and view all the flashcards
Mass-forming subtype
Mass-forming subtype
Signup and view all the flashcards
Infiltrative subtype
Infiltrative subtype
Signup and view all the flashcards
Hepatocytes
Hepatocytes
Signup and view all the flashcards
Kupffer cells
Kupffer cells
Signup and view all the flashcards
Cholangiocytes
Cholangiocytes
Signup and view all the flashcards
Chronic inflammation
Chronic inflammation
Signup and view all the flashcards
Microenvironment cell interactions
Microenvironment cell interactions
Signup and view all the flashcards
Genetic and epigenetic alterations
Genetic and epigenetic alterations
Signup and view all the flashcards
Deregulated signaling pathways
Deregulated signaling pathways
Signup and view all the flashcards
Angiogenesis
Angiogenesis
Signup and view all the flashcards
Gross Appearance of IHCC
Gross Appearance of IHCC
Signup and view all the flashcards
Mass-forming IHCC
Mass-forming IHCC
Signup and view all the flashcards
Periductal IHCC
Periductal IHCC
Signup and view all the flashcards
Specula-forming IHCC
Specula-forming IHCC
Signup and view all the flashcards
Pathogenesis of IHCC
Pathogenesis of IHCC
Signup and view all the flashcards
Hepatic Progenitor Cells
Hepatic Progenitor Cells
Signup and view all the flashcards
Lymph Node Dissection During Hepatectomy
Lymph Node Dissection During Hepatectomy
Signup and view all the flashcards
Stage I IHCC
Stage I IHCC
Signup and view all the flashcards
Stage II IHCC
Stage II IHCC
Signup and view all the flashcards
Hepatectomy
Hepatectomy
Signup and view all the flashcards
Extended Hepatectomy
Extended Hepatectomy
Signup and view all the flashcards
Studies on Lymphadenectomy in IHCC
Studies on Lymphadenectomy in IHCC
Signup and view all the flashcards
Evidence Suggesting Limited Benefit of Lymphadenectomy
Evidence Suggesting Limited Benefit of Lymphadenectomy
Signup and view all the flashcards
Investigative Treatments for IHCC
Investigative Treatments for IHCC
Signup and view all the flashcards
Study Notes
Intrahepatic Cholangiocarcinoma
- Intrahepatic cholangiocarcinoma (IHCC) is a primary liver malignancy.
- Also known as peripheral cholangiocarcinoma, cholangiolar cancer, or cholangiocellular carcinoma.
- IHCC accounts for 10% of primary hepatic malignancies.
- Tumors often present with advanced disease.
- Surgical resection is the only known potentially curative therapy.
- Active systemic therapies are limited.
Epidemiology and Demographics
- Incidence of cholangiocarcinoma is increasing worldwide.
- IHCC is the second most common primary liver cancer after hepatocellular carcinoma.
- Incidence in the US is 0.85 per 100,000 population.
- Highest worldwide incidence in Northeast Thailand (96 per 100,000).
- Typically diagnosed in the seventh decade of life.
- More common in men.
Etiology and Risk Factors
- Most IHCC cases have no known risk factors.
- Primary sclerosing cholangitis (PSC) is the most common risk factor in the West.
- Increased risk of developing cholangiocarcinoma in patients with PSC
- PSC is associated with inflammatory bowel disease, increasing the risk of cholangiocarcinoma.
- Patients with PSC develop cholangiocarcinoma 2-3 decades earlier than sporadic cases.
- Chronic infection with liver flukes (Opisthorchis viverrini and Clinorchis sinensis) is linked to increased risk in Southeast Asia.
- Chronic hepatolithiasis (gallstones in the liver) and recurrent pyogenic cholangitis are also associated risk factors.
- Congenital biliary cystic disease increases the risk of malignant change.
- Infections with hepatitis C and B viruses are associated with an increased risk.
- Other factors: cirrhosis, nonalcoholic steatohepatitis, diabetes, and obesity.
Pathogenesis
- Cholangiocarcinoma arises from malignant transformation of cholangiocytes (cells lining the bile ducts).
- Chronic inflammation is a key factor in malignant transformation.
- Chronic inflammation can lead to biliary obstruction and increased cholangiocyte turnover, causing DNA damage and promoting growth.
- Genetic and metabolic anomalies contribute to carcinogenesis.
Pathologic Subtypes
- IHCCs can range from firm, white sclerotic masses to infiltrative.
- Different subtypes with varied behavior are recognized: mass-forming, periductal, and intraductal tumors.
Imaging
- Ultrasound is used as a screening tool if suspicion for IHCC based on symptoms.
- Triple-phase CT scans are highly effective for diagnosis of IHCC.
- MRI with MRCP is increasingly used for biliary malignancy diagnosis and staging, including for assessing vascular involvement and hepatic lobar atrophy.
- PET scans are used for staging to detect distant metastases and lymph node involvement.
Treatment options
- Surgery is considered the definitive treatment for resectable IHCC.
- Surgical resection requires careful consideration of vascular involvement and the extent of the tumor, especially in the presence of severe liver disease.
- Tumor ablation (radiofrequency, microwave) is a promising non-surgical option.
- Transarterial chemoembolization (TACE) is commonly used in patients with unresectable disease.
- Orthotopic liver transplantation is an option for unresectable tumors without distant spread, and neoadjuvant chemoradiation is recommended before transplantation.
- Chemotherapy and radiation therapy are used for advanced stages, but are still considered experimental.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Test your knowledge on intrahepatic cholangiocarcinoma (IHCC) with this quiz. Explore its incidence, common risk factors, diagnostic challenges, and survival benefits of surgical procedures. Gain insights into the classification systems used for staging IHCC.